title: The nonhomologous end joining factor Artemis suppresses multi-tissue tumor formation and prevents loss of heterozygosity.
abstract: Nonhomologous end joining (NHEJ) is a critical DNA repair pathway, with proposed tumor suppression functions in many tissues. Mutations in the NHEJ factor ARTEMIS cause radiation-sensitive severe combined immunodeficiency in humans and may increase susceptibility to lymphoma in some settings. We now report that deficiency for Artemis (encoded by Dclre1c/Art in mouse) accelerates tumorigenesis in several tissues in a Trp53 heterozygous setting, revealing tumor suppression roles for NHEJ in lymphoid and non-lymphoid cells. We also show that B-lineage lymphomas in these mice undergo loss of Trp53 heterozygosity by allele replacement, but arise by mechanisms distinct from those in Art Trp53 double null mice. These findings demonstrate a general tumor suppression function for NHEJ, and reveal that interplay between NHEJ and Trp53 loss of heterozygosity influences the sequence of multi-hit oncogenesis. We present a model where p53 status at the time of tumor initiation is a key determinant of subsequent oncogenic mechanisms. Because Art deficient mice represent a model for radiation-sensitive severe combined immunodeficiency, our findings suggest that these patients may be at risk for both lymphoid and non-lymphoid cancers.
authors: The Jackson Laboratory, Bar Harbor, ME 04609, USA.
authors: Y
authors: Y
authors: Woo
authors: S M
authors: SM
authors: Wright
authors: S A
authors: SA
authors: Maas
authors: T L
authors: TL
authors: Alley
authors: L B
authors: LB
authors: Caddle
authors: S
authors: S
authors: Kamdar
authors: J
authors: J
authors: Affourtit
authors: O
authors: O
authors: Foreman
authors: E C
authors: EC
authors: Akeson
authors: D
authors: D
authors: Shaffer
authors: R T
authors: RT
authors: Bronson
authors: H C
authors: HC
authors: Morse
authors: D
authors: D
authors: Roopenian
authors: K D
authors: KD
authors: Mills
mesh_terms: D000818:Animals; D004260:DNA Repair; D004720:Endonucleases; D016158:Genes, p53; D006801:Humans; D019656:Loss of Heterozygosity; D008223:Lymphoma / Q000235:genetics / Q000473:pathology; D051379:Mice; D018345:Mice, Knockout; D009369:Neoplasms / Q000235:genetics* / Q000473:pathology*; D009687:Nuclear Proteins / Q000172:deficiency / Q000235:genetics*; D012513:Sarcoma, Experimental / Q000235:genetics / Q000473:pathology; D016511:Severe Combined Immunodeficiency / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000172:deficiency
chemical_list: D009687:Nuclear Proteins; D016159:Tumor Suppressor Protein p53; D004720:Endonucleases; C473337:Dclre1c protein, mouse